Summary
Substitution of diseased organ/tissues with totally artificial machines or transplantable biohybrid devices where functionally competent cells are enveloped within immunoprotective artificial membranes could represent one of the future goals in medicine. In particular, artificial or, closer to feasibility, biohybrid artificial pancreas (BHAP) could replace the function of pancreatic islet β-cells that have been destroyed by autoimmunity, thereby obviating the need to treat patients with type 1 diabetes mellitus (T1DM) with multiple daily insulin injections. State-of-the-art diabetes therapy and perspectives in the use of BHAP, with special regard to islet-cell-containing microcapsules fabricated with alginate-based polymers, including applications to experimental animal models according to different chemical procedures, are reviewed. Special emphasis has been given to preparation methods, immunoprotection strategies, and biocompatibility of the islet-cell-containing microbarriers, as well as to approaches to ameliorate these features. Currently available BHAP prototypes have been critically reviewed to define expectations about the next generation devices targeting the final cure of T1DM.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Colton, C. K. (1995) Implantable biohybrid artificial organ. Cell Transplant. 4, 415–436.
Williams, R. (1998) The burden of diabetes in the next millennium. Diabetes Rev. Int. 7(3), 21–27.
American Diabetes Association (position statement) (2005) Standard of medical care in diabetes, Diabetes Care 28(Suppl. 1), S4–S36.
Calafiore, R. (1997) Perspectives in pancreatic and islet cell transplantation for the therapy of IDDM, Diabetes Care 20, 889–896.
Ryan, E. A., Bigam, D., and Shapiro, A. M. (2006) Current indications for pancreas or islet transplant. Diabetes Obes. Metab. 8, 1–7.
International Islet Transplant Registry (1999) Newsletter 8, 1.
Shapiro, A. M., Lakey, J. R., Paty, B. W., Senior, P. A., Bigam, D. L., and Ryan, E. A. (2005) Strategic opportunities in clinical islet transplantation. Transplantation 79, 1304–1307.
Korbutt, G. S., Elliott, J. F., Ao, Z., Smith, D. K., Warnock, G. L., and Rajotte, R. V. (1996) Large scale isolation, growth, and function of porcine neonatal islet cells. J. Clin. Invest. 97, 2119–2129.
Hunkeler, D., Sun, A. M., Rajotte, R., Gill, R., Calafiore, R., and Morel, P. (1999) Bioartificial organs and acceptable risk. Nat. Biotechnol. 17, 1045.
Toso, C., Mathe, Z., Morel, P., Oberholzer, J., Bosco, D., Sainz-Vidal, D., Hunkeler, D., Buhler, L. H., Wandrey, C., and Berney, T. (2005) Effect of microcapsule composition and short-term immunosuppression on intraportal biocompatibility. Cell Transplant. 14, 159–167.
Orive, G., Hernandez, R. M., Gascon, A. R., Calafiore, R., Chang, T. M., de Vos, P., Hortelano, G., Hunkeler, D., Lacik, I., Shapiro, A. M., and Pedraz, J. L. (2003) Cell encapsulation: promise and progress. Nat. Med. 9, 104–107.
Petruzzo, P., Pibiri, L., De Giudici, M. A., Basta, G., Calafiore, R., Falorni, A., Brunetti, P., and Brotzu, G. (1991) Xenotransplantation of microencapsulated pancreatic islets contained in a vascular prosthesis: preliminary results. Transpl. Int. 4, 200–204.
acy, P. E., Hegre, O. D., Gerasimidi-Vazeou, A., Gentile, F. T., and Dionne, K. E. (1991) Subcutaneous xenografts of rat islets in acrylic copolymer capsules maintain normoglycemia in diabetic mice. Science 254, 1782–1784.
Lanza, R. P., Beyer, A. M., Staruk, J. E., and Chick, W. L. (1993) Biohybrid artificial pancreas: long-term function of discordant islet xenografts in streptozotocin-diabetic rats. Transplantation 56, 1067–1072.
Lanza, R. P., Borland, K. M., Staruk, J. E., Appel, M. C., Solomon, B. A., and Chick, W. L. (1992) Transplantation of encapsulated canine islets into spontaneously diabetic BB/Wor rats without immunosuppression. Endocrinology 131, 637–642.
de Vos, P., Hillebrands, J. L., De Haan, B. J., Strubbe, J. H., and Van Schilfgaarde, R. (1997) Efficacy of a prevascularized expanded polytetrafluoroethylene solid support system as a transplantation site for pancreatic islets. Transplantation 63, 824–830.
Maki, T., Otsu, I., O’Neil, J. J., Dunleavy, K., Mullon, C. J., Solomon, B. A., and Monaco, A. P. (1996) Treatment of diabetes by xenogeneic islets without immunosuppression: use of a vascularized bioartificial pancreas. Diabetes 45, 342–347.
Calafiore, R. (1992) Transplantation of microencapsulated pancreatic human islets for the therapy of diabetes mellitus: a preliminary report. ASAIO J. 38, 34–37.
Kizilel, S., Garfinkel, M., and Opara, E. (2005) The bioartificial pancreas: progress and challenges. Diabetes Technol. Ther. 7, 968–985.
Duvivier-Kali, V. F., Omer, A., Parent, R. J., O’Neill, and Weir, G. C. (2001) Complete protection of islets against allorejection and autoimmunity by a simple barium alginate membrane. Diabetes 50, 1698–1705.
Iwata, H., Amemiya, H., Matsuda, T., Takano, H., Hayashi, R., and Akutsu, T. (1989) Evaluation of microencapsulated islets in agarose gel as bioartificial pancreas by studies of hormone secretion in culture and by xenotransplantation. Diabetes 38(Suppl. 1), 224–225.
Cruise, G. N., Hegre, O. D., Lamberti, F. V., Hager, S. R., Hill, R., Scharp, D. S., and Hubbell, J. A. (1999) In vitro and in vivo performance of porcine islets encapsulated in interfacially photopolymerized poly(ethylene glycol) diacrylate membranes. Cell Transplant. 8, 293–306.
Zielinski, B. A. and Aebischer, P. (1994) Chitosan as a matrix for mammalian cell encapsulation. Biomaterials 15, 1049–1056.
Dawson, R. M., Broughton, R. L., Stevenson, W. T., and Sefton, M. V. (1987) Microencapsulation of CHO cells in a hydroxyethyl-methacrylate methyl methacrylate copolymer. Biomaterials 8, 360–366.
Kessler, L., Pinget, M., Aprahaim, M., Dejardin, P., and Damge, C. (1991) In vitro and in vivo studies of the properties of an artificial membrane for pancreatic islet encapsulation. Horm. Metab. Res. 23, 312–317.
Calafiore, R., Basta, G., Luca, G., Lemmi, A., Montanucci, M. P., Calabrese, G., Racanicchi, L., Mancuso, F., and Brunetti, P. (2006) Microencapsulated pancreatic islet allografts into nonimmunosuppressed patients with type 1 diabetes: first two cases. Diabetes Care 29, 137–138.
Lim, F. and Sun, A. M. (1980) Microencapsulated islets as bioartificial endocrine pancreas. Science 210, 908–910.
Hunkeler, D., Prokop, A., Powers, A., Haralson, M., DiMari, S., and Wang, T. (1997) A screening of polymers as biomaterials for cell encapsulation. Polymer News 22, 232.
Draget, K. I., Skjak-Braek, G., and Smidsrod, O. (1997) Alginate based new materials. Int. J. Biol. Macromol. 21, 47–55.
30 Calafiore, R., Basta, G., Osticioli, L., Luca, G., Tortoioli, C., and Brunetti, P. (1996) Coherent microcapsules for pancreatic islet transplantation: a new approach for bioartificial pancreas. Transplant. Proc. 28, 812–813.
Duvivier-Kali, V. F., Omer, A., Lopez-Avalos, M. D., O’Neil, J. J., and Weir, G. C. (2004) Survival of microencapsulated adult pig islets in mice in spite of an antibody response. Am. J. Transplant. 4, 1991–2000.
Strand, B. L., Gaserod, O., Kulseng, B., Espevik, T., and Skjak-Baek, G. (2002) Alginate-polylysine-alginate microcapsules: effect of size reduction on capsule properties. J. Microencapsul. 19, 615–630.
Luca, G., Nastruzzi, C., Calvitti, M., Becchetti, E., Baroni, T., Neri, L. M., Capitani, S., Basta, G., Brunetti, P., and Calafiore, R. (2005) Accelerated functional maturation of isolated neonatal porcine cell clusters: in vitro and in vivo results in NOD mice. Cell Transplant. 14, 249–261.
Calafiore, R., Basta, G., Falorni, A., Calcinaro, F., Pietropaolo, M., and Brunetti, P. (1992) A method for the large-scale production of microencapsulated islets: in vitro and in vivo results. Diabetes Nutr. Metab. 5, 23.
Lanza, R. P. (1995) Encapsulation technologies. Tissue Eng. 1, 18.
de Vos, P., Wolters, G. H., and van Schilfgaarde, R. (1994) Possible relationship between fibrotic overgrowth of alginate-polylysine-alginate microencapsulated pancreatic islets and the microcapsule integrity. Transplant. Proc. 26, 782–783.
Sawhney, A., Pathak, C. P., and Hubbell, J. A. (1994) Modification of Langerhans islet surfaces with immunoprotective poly(ethylene glycol) coatings. Biotech. Bioeng. 44, 383.
Calafiore, R., Basta, G., Osticioli, L., Luca, G., Tortoioli, C., and Brunetti, P. (1996) Coherent microcapsules for pancreatic islet transplantation: a new approach for bioartificial pancreas. Transplant. Proc. 28, 812–813.
Brunetti, P., Basta, G., Faloerni, A., Calcinaro, F., Pietropaolo, M., and Calafiore, R. (1991) Immunoprotection of pancreatic islet grafts within artificial microcapsules. Int. J. Artif. Organs 14, 789–791.
Soon-Shiong, P., Feldman, E., Nelson, R., Komtebedde, J., Smidsrod, O., Skjak-Braek, G., Espevik, T., Heintz, R., and Lee, M. (1992) Successful reversal of spontaneous diabetes in dogs by intraperitoneal microencapsulated islets. Transplantation 54, 769–774.
Sun, X., Ma, X., Zhou, D., Vacek, I., and Sun, A. M. (1996) Normalization of diabetes in spontaneously diabetic cynomologous monkeys by xenografts of microencapsulated porcine islets without immunosuppression. J. Clin. Invest. 98,1417–1422.
Elliott, R. B., Escobar, L., Tan, P. L., Garkavenko, O., Calafiore, R., Basta, P., Vasconcellos, A. V., Emerich, D. F., Thanos, C., and Bambra, C. (2005) Intraperitoneal alginate-encapsulated neonatal porcine islets in a placebo-controlled study with 16 diabetic cynomolgus primates. Transplant. Proc. 37, 3505–3508.
Wu, H., Avgoustiniatos, E. S., Swette, L., Bonner-Weir, S., Weir, G. C., and Colton, C. K. (1999) In situ electrochemical oxygen generation with an immunoisolation device. Ann. N. Y. Acad. Sci. 875, 105–125.
Desai, T. A., Chu, W. H., Rasi, G., Sinibaldi-Vallebona, P., Guarino, E., and Ferrari, M. (1999) Microfabricated biocapsules provide short-term immunoisolation of insulinoma xenografts. Biomed. Microdevices 1, 131–138.
Basta, G., Sarchielli, P., Luca, G., Racanicchi, L., Nastruzzi, C., Guido, L., Mancuso, F., Macchiarulo, G., Calabrese, G., Brunetti, P., and Calafiore, R. (2004) Optimized parameters for microencapsulation of pancreatic islet cells: an in vitro study clueing on islet graft immunoprotection in type 1 diabetes mellitus. Transplant. Immunol. 13, 289–296.
Hering, B. J., Wijkstrom, M., Graham, M. L., Hardstedt, M., Aasheim, T. C., Jie, T., Ansite, J. D., Nakano, M., Cheng, J., Li, W., Moran, K., Christians, U., Finnegan, C., Mills, C. D., Sutherland, D. E., Bansal-Pakala, P., Murtaugh, M. P., Kirchhof, N., and Schuurman, H. J. (2006) Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates. Nat. Med. 12, 301–303.
Cardona, K., Korbutt, G. S., Milas, Z., Lyon, J., Cano, J., Jiang, W., Bello-Laborn, H., Hacquoil, B., Strobert, E., Gangappa, S., Weber, C. J., Pearson, T. C., Rajotte, R. V., and Larsen, C. P. (2006) Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways. Nat. Med. 12, 304–306.
Patience, C., Takeuchi, Y., and Weiss, R. A. (1997) Infection of human cells by an endogenous retrovirus of pigs. Nat. Med. 3, 282–286.
Fishman, J. A. and Patience, C. (2004) Xenotransplantation: infectious risk revisited. Am. J. Transplant. 4, 1383–1390.
Lindeborg, E., Kumagai-Braesch, M., Tibell, A., Christensson, B., and Moller, E. (2004) Biological activity of pig islet-cell reactive IgG antibodies in xenotransplanted diabetic patients. Xenotransplantation 11, 457–470.
Valdes-Gonzalez, R. A., Dorantes, L. M., Garibay, G. N., Bracho-Blanchet, E., Mendez, A. J., Davila-Perez, R., Elliott, R. B., Teran, L., and White, D. J. (2005) Xenotransplantation of porcine neonatal islets of Langerhans and Sertoli cells: a 4-year study. Eur. J. Endocrinol. 153, 419–427.
Elliott, R. B., Escobar, L., Garkavenko, O., Croxson, M. C., Schroeder, B. A., McGregor, M., Ferguson, G., Beckman, N., and Ferguson, S. (2000) No evidence of infection with porcine endogenous retrovirus in recipients of encapsulated porcine islet xenografts. Cell Transplant. 9, 895–901.
Pakhomov, O., Martignat, L., Honiger, J., Clemenceau, B., Sai, P., and Darquy, S. (2005) AN69 hollow fiber membrane will reduce but not abolish the risk of transmission of porcine endogenous retroviruses. Cell Transplant. 14, 749–756.
Gill, R. G. and Wolf, L. (1995) Immunobiology of cellular transplantation. Cell Transplant. 4, 361–370.
Grewal, I. S. and Flavell, R. A. (1998) CD40 and CD154 in cell-mediated immunity. Ann. Rev. Immunol. 16, 111–135.
Weber, C. J., Safley, S., Hagler, M., and Kapp, J. (1999) Evaluation of graft-host response for various tissue resources and animal models. Ann. N. Y. Acad. Sci. 875, 233–254.
Rayat, G. R., Rajotte, R. V., and Korbutt, G. S. (1999) Potential application of neonatal porcine islets as treatment for type 1 diabetes: a review. Ann. N. Y. Acad. Sci. 875, 175–188.
Gill, R. G. (1999) Antigen presentation pathways for immunity to islet transplants: relevance to immunoisolation. Ann. N. Y. Acad. Sci. 875, 255–260.
Ricci, M., Blasi, P., Giovagnoli, S., Rossi, C., Macchiarulo, G., Luca, G., Basta, G., and Calafiore, R. (2005) Ketoprofen controlled release from composite microcapsules for cell encapsulation: effect on post-transplant acute inflammation. J. Control Release 107, 395–407.
Luca, G., Nastruzzi, C., Basta, G., Brozzetti, A., Saturni, A., Mughetti, D., Ricci, M., Rossi, C., Brunetti, P., and Calafiore, R. (2000) Effects of anti-oxidizing vitamins on in vitro cultured porcine neonatal pancreatic islet cells. Diabetes Nutr. Metab. 13, 301–307.
Lanza, R. P., Ecker, D. M., Kuhtreiber, W. M., Marsh, J. P., Ringeling, J., and Chick, W. L. (1999) Transplantation of islets using microencapsulation: studies in diabetic rodents and dogs. J. Mol. Med. 77, 206–210.
Fan, M. Y., Lum, Z. P., Fu, X. W., Levesque, L., Tai, I. T., and Sun, A. M. (1990) Reversal of diabetes in BB rats by transplantation of encapsulated pancreatic islets. Diabetes 39, 519–522.
Lum, Z. P., Tai, I. T., Krestow, M., Norton, J., Vacek, I., Sun, A. M. (1991) Prolonged reversal of diabetic state in NOD mice by xenografts of microencapsulated rat islets. Diabetes 40, 1511–1516.
Soon-Shiong, P., Heintz, R. E., Merideth, N., Yao, Q. X., Yao, Z., Zheng, T., Murphy, M., Moloney, M. K., Schmehl, M., and Harris, M. (1994) Insulin-independence in a type I diabetic patient after encapsulated islet transplantation. Lancet 343, 950–951.
Dufour, J. M., Rajotte, R. V., Zimmerman, M., Rezania, A., Kin, T., Dixon, D. E., and Korbutt, G. (2005) Development of an ectopic site for islet transplantation, using biodegradable scaffolds. Tissue Eng. 11, 1323–1331.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Humana Press Inc.
About this protocol
Cite this protocol
Calafiore, R., Basta, G. (2007). Artificial Pancreas to Treat Type 1 Diabetes Mellitus. In: Hauser, H., Fussenegger, M. (eds) Tissue Engineering. Methods in Molecular Medicine™, vol 140. Humana Press. https://doi.org/10.1007/978-1-59745-443-8_12
Download citation
DOI: https://doi.org/10.1007/978-1-59745-443-8_12
Publisher Name: Humana Press
Print ISBN: 978-1-58829-756-3
Online ISBN: 978-1-59745-443-8
eBook Packages: Springer Protocols